Previous Article | Next Article 
Journal of Clinical Microbiology, February 2000, p. 863-865, Vol. 38, No. 2
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Clinical Evaluation of the BDProbeTec ET System for
Rapid Detection of Mycobacterium tuberculosis
John S.
Bergmann,1
William E.
Keating,2 and
Gail L.
Woods1,*
Department of Pathology, University of Texas
Medical Branch, Galveston, Texas,1 and
BD Biosciences, Sparks, Maryland2
Received 9 August 1999/Returned for modification 27 September
1999/Accepted 8 November 1999
The performance of the BDProbeTec ET system (BD Biosciences,
Sparks, Md.) for direct detection of Mycobacterium
tuberculosis complex (MTBC) in respiratory specimens was
evaluated by comparing results to those of conventional mycobacterial
culture performed with the BACTEC 460 TB system and Middlebrook 7H11
biplates. Patients known to have been on antituberculous therapy were
excluded from the analysis. Of 600 evaluable specimens (4 specimens
were excluded from the analysis due to failure of the internal
amplification control [IAC]) from 332 patients, 57 grew mycobacteria;
16 were MTBC (from 12 patients), and 41 were nontuberculous
mycobacteria. Of the 16 MTBC culture-positive specimens, 12 were smear
positive and 4 were smear negative. BDProbeTec ET detected 14 of the 16 MTBC culture-positive specimens, resulting in initial overall sensitivity, specificity, and positive and negative predictive values
of 87.5, 99.0, 70.0, and 99.7%, respectively. After resolution of
discrepancies by review of medical records and retesting of samples
yielding discordant MTBC culture and BDProbeTec ET results, the revised
overall sensitivity, specificity, and positive and negative predictive
values of the BDProbeTec ET were respectively 93.8, 99.8, 93.8, and
99.8% by specimen and 91.7, 99.7, 91.7, and 99.7% by patient. The
BDProbeTec ET System offers the distinct advantage of including an IAC
in the specimen well. These data suggest that the test performance is
very good, especially for smear-positive samples. However, the number
of patients with tuberculosis in our study, especially those with
smear-negative disease, was small; therefore, additional studies are needed.
*
Corresponding author. Mailing address: Department of
Pathology, University of Texas Medical Branch, Galveston, TX
77555-0740. Phone: (409) 772-4851. Fax: (409) 772-5683. E-mail:
gwoods{at}utmb.edu.
Journal of Clinical Microbiology, February 2000, p. 863-865, Vol. 38, No. 2
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bean, D. C., Hills, A., Ryan, T., Aitken, J.
(2007). Evaluation of the BD ProbeTec ET System for Direct Detection of Mycobacterium bovis in Veterinary Specimens. J. Clin. Microbiol.
45: 3434-3435
[Abstract]
[Full Text]
-
Greco, S, Girardi, E, Navarra, A, Saltini, C
(2006). Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax
61: 783-790
[Abstract]
[Full Text]
-
Wang, J.-Y., Lee, L.-N., Hsu, H.-L., Hsueh, P.-R., Luh, K.-T.
(2006). Performance Assessment of the DR. MTBC Screen Assay and the BD ProbeTec ET System for Direct Detection of Mycobacterium tuberculosis in Respiratory Specimens. J. Clin. Microbiol.
44: 716-719
[Abstract]
[Full Text]
-
Palomino, J. C.
(2005). Nonconventional and new methods in the diagnosis of tuberculosis: feasibility and applicability in the field. Eur Respir J
26: 339-350
[Abstract]
[Full Text]
-
Goessens, W. H. F., de Man, P., Koeleman, J. G. M., Luijendijk, A., te Witt, R., Endtz, H. P., van Belkum, A.
(2005). Comparison of the COBAS AMPLICOR MTB and BDProbeTec ET Assays for Detection of Mycobacterium tuberculosis in Respiratory Specimens. J. Clin. Microbiol.
43: 2563-2566
[Abstract]
[Full Text]
-
Wang, J.-Y., Lee, L.-N., Chou, C.-S., Huang, C.-Y., Wang, S.-K., Lai, H.-C., Hsueh, P.-R., Luh, K.-T.
(2004). Performance Assessment of a Nested-PCR Assay (the RAPID BAP-MTB) and the BD ProbeTec ET System for Detection of Mycobacterium tuberculosis in Clinical Specimens. J. Clin. Microbiol.
42: 4599-4603
[Abstract]
[Full Text]
-
Johansen, I. S., Thomsen, V. O., Forsgren, A., Hansen, B. F., Lundgren, B.
(2004). Detection of Mycobacterium tuberculosis Complex in Formalin-Fixed, Paraffin-Embedded Tissue Specimens with Necrotizing Granulomatous Inflammation by Strand Displacement Amplification. J. Mol. Diagn.
6: 231-236
[Abstract]
[Full Text]
-
Johansen, I. S., Lundgren, B., Tabak, F., Petrini, B., Hosoglu, S., Saltoglu, N., Thomsen, V. O.
(2004). Improved Sensitivity of Nucleic Acid Amplification for Rapid Diagnosis of Tuberculous Meningitis. J. Clin. Microbiol.
42: 3036-3040
[Abstract]
[Full Text]
-
Wang, S. X., Sng, L. H., Tay, L.
(2004). Preliminary study on rapid identification of Mycobacterium tuberculosis complex isolates by the BD ProbeTec ET system. J Med Microbiol
53: 57-59
[Abstract]
[Full Text]
-
Piersimoni, C., Scarparo, C.
(2003). Relevance of Commercial Amplification Methods for Direct Detection of Mycobacterium tuberculosis Complex in Clinical Samples. J. Clin. Microbiol.
41: 5355-5365
[Full Text]
-
Mazzarelli, G., Rindi, L., Piccoli, P., Scarparo, C., Garzelli, C., Tortoli, E.
(2003). Evaluation of the BDProbeTec ET System for Direct Detection of Mycobacterium tuberculosis in Pulmonary and Extrapulmonary Samples: a Multicenter Study. J. Clin. Microbiol.
41: 1779-1782
[Abstract]
[Full Text]
-
Piersimoni, C., Scarparo, C., Piccoli, P., Rigon, A., Ruggiero, G., Nista, D., Bornigia, S.
(2002). Performance Assessment of Two Commercial Amplification Assays for Direct Detection of Mycobacterium tuberculosis Complex from Respiratory and Extrapulmonary Specimens. J. Clin. Microbiol.
40: 4138-4142
[Abstract]
[Full Text]
-
BARRETT, A., MAGEE, J. G., FREEMAN, R.
(2002). An evaluation of the BD ProbeTec ET system for the direct detection of Mycobacterium tuberculosis in respiratory samples. J Med Microbiol
51: 895-898
[Abstract]
[Full Text]